It has been suggested that Hsp90 up-regulation may be a sign of poor disease prognosis [47] and a recent study has demonstrated that co-expression of HSP90 and PI3K or expression of HSP90 in combination with the loss of PTEN were associated with significantly worse recurrence-free survival in patients with breast cancer [84]. Here, HSP90AB1 is linked to breast cancer.